您的位置: 首页 > 农业专利 > 详情页

Methods for Treating Hyperbilirubinemia with Stannsoporfin
专利权人:
INFACARE PHARMACEUTICAL CORPORATION
发明人:
Simon J. Tulloch,Warren W. Wasiewski
申请号:
US16505295
公开号:
US20200016167A1
申请日:
2019.07.08
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Some embodiments relate to methods of treating hyperbilirubinemia comprising administrating a therapeutic amount of a metalloporphyrin to an infant. Administration may occur when the infant's measured total serum bilirubin levels are at or below about the level suggested by the AAP nomogram for initiating phototherapy, when the infant's measured total serum bilirubin levels are at about the level suggested for initiating phototherapy in an infant, or when the infant's measured total serum bilirubin levels are at about the level suggested for initiating phototherapy. Administration may occur without regard to the total serum bilirubin level of the infant. In some embodiments, administration of the metalloporphyrin does not cause QT prolongation.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充